Mutation status in yes-associated protein 1 (YAP1) in an insulinoma cell line Rin-5F
1Department of Life Sciences, Faculty of Science, Okayama University of Science, Okayama, 700-0005, Japan.
Cancer Genetics
|March 30, 2025
Summary
YAP1 gene mutations may predict immunotherapy response. Researchers found no YAP1 mutations in insulinoma cells, suggesting reduced effectiveness of immune checkpoint inhibitors for these neuroendocrine tumors, warranting further clinical trials.
Area of Science:
- Oncology
- Genetics
- Immunotherapy
Background:
- YAP1 gene mutations are linked to enhanced responses to immune checkpoint inhibitors (ICIs) in various cancers.
- YAP1 mutations may serve as a predictive biomarker for immunotherapy efficacy.
- The YAP1 gene status in insulinoma, a type of neuroendocrine tumor, has not been previously documented.
Purpose of the Study:
- To investigate the presence of YAP1 gene mutations in the insulin-secreting pancreatic cell line Rin-5F.
- To explore the potential implications of YAP1 gene status on the efficacy of immune checkpoint inhibitors in insulinoma.
Main Methods:
- Genomic DNA and complementary DNA were extracted from Rin-5F cells.
- The YAP1 gene was analyzed for mutations using established molecular techniques.
Main Results:
- No mutations in the YAP1 gene were identified in the Rin-5F insulinoma cell line.
- This finding contrasts with previous reports linking YAP1 mutations to immunotherapy response in other cancers.
Conclusions:
- The absence of YAP1 mutations in this insulinoma cell line suggests that ICIs may have a limited impact on these neuroendocrine tumors.
- Further clinical trials investigating immune checkpoint inhibitors for neuroendocrine tumors, including insulinomas, are necessary to validate these findings.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...